SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 11th, 2024 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Nevada
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 1, 2024, by and between Propanc Biopharma, Inc., a Delaware corporation, with headquarters located at 302, 6 Butler Street, Camberwell, VIC 3124, Australia (the “Company”), and 104 LLC, a Nevada limited liability company, with its address at 21520 Yorba Linda Blvd., Suite G PMB 335, Yorba Linda, CA 92887 (the “Buyer”).
